# SBC Medical Group Holdings Inc > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/SBC Medical Group Holdings Inc). ## Overview SBC Medical Group Holdings Inc. is a U.S.-listed medical services company with operations centered in Japan and a management base in Irvine, California and Tokyo. Through its subsidiaries, it provides franchise and management services to cosmetic treatment centers, supporting clinic operations, branding, procurement, technology, and patient-facing services. ## Products & services • Franchising and clinic management services • Advertising, marketing, and reservation support • Staff recruitment, training, and housing support • Medical equipment, consumables, and cosmetic product procurement • Brand, trademark, and medical technology licensing • IT software and remote consultation tools - **Franchising and management services** (45%) — Core clinic support services provided to franchisee and affiliated medical corporations. - **Procurement and resale** (25%) — Medical equipment, consumables, and cosmetic products supplied to clinics for resale or use. - **Rental services** (15%) — Equipment and related rental services supporting clinic openings and operations. - **Technology and licensing** (10%) — Software, remote consultation tools, and licensing of brand and medical technologies. - **Other services** (5%) — Ancillary services such as marketing support, booking, and facility-related assistance. - Franchising and clinic management services - Advertising, marketing, and reservation support - Staff recruitment, training, and housing support - Medical equipment, consumables, and cosmetic product procurement - Brand, trademark, and medical technology licensing - IT software and remote consultation tools ## Customers The company serves medical corporations, franchisee clinics, and related clinic operators that run cosmetic and aesthetic treatment centers. Its customers buy operating support, procurement, and brand/technology access because these services help clinics standardize operations, attract patients, and expand capacity. - **Franchisee medical corporations** (primary) — Buy management, marketing, procurement, and brand support to run cosmetic clinics under the SBC model. - **Related affiliated clinic operators** (primary) — Use service contracts for clinic operations support, technology, and purchasing. - **Independent clinics** (secondary) — Receive similar management services without being part of the core franchise structure. - **Clinic patients** (primary) — End customers of the treatment centers who drive demand for cosmetic procedures and related services. - Franchisee medical corporations operating cosmetic treatment centers - Related clinic operators using management and procurement services - Independent clinics receiving similar support services - Clinic operators seeking branding, booking, and patient loyalty tools - Operators needing equipment, consumables, and facility support ## Geography The business is primarily conducted in Japan, where its subsidiary SBC Medical Sub supports 258 treatment centers as of September 30, 2025. The company is headquartered in Irvine, California and Tokyo, but its operating footprint, revenue exposure, and foreign exchange sensitivity are centered on Japan and the Japanese yen. - Primary operating market is Japan - Supports 258 treatment centers in Japan - Headquartered in Irvine, California and Tokyo - Revenue and costs are largely yen-denominated - Foreign exchange exposure is tied to JPY/USD movements ## Strategy The company’s strategy is to expand its role as a management platform for cosmetic treatment centers, combining franchising, procurement, technology, and clinic support services. It also evaluates capital allocation options, including selective investment in the global medical aesthetics market and potential shareholder returns through dividends or repurchases. - **Grow the clinic services platform** (medium-term) — A larger network of supported clinics increases recurring service and procurement opportunities. - **Deepen product and technology integration** (medium-term) — Bundling software, licensing, and procurement strengthens clinic dependence on the platform. - **Allocate capital selectively** (short-term) — Management seeks to balance growth investments with shareholder returns and liquidity needs. - Expand management services across cosmetic treatment centers - Support clinic openings and equipment replacement demand - Broaden service contracts with affiliated medical corporations - Invest selectively in the global medical aesthetics market - Evaluate dividends and share repurchases as capital uses ## Risks The business depends on a concentrated set of related-party medical corporations and franchisee clinics, so disruptions at those operators can affect revenue and service demand. It is also exposed to Japan-specific regulatory, staffing, and foreign exchange risks because most operations and cash flows are yen-based while reporting is in U.S. dollars. - **Concentration of revenue among affiliated clinic operators** [high] — The company relies on a limited number of franchisor-franchisee and service contracts. - **Related-party governance and control limitations** [high] — Several clinic operators are related parties, but the company does not have full voting control over them. - **Foreign exchange volatility** [medium] — Most revenues and costs are denominated in Japanese yen while reporting is in U.S. dollars. - **Regulatory and licensing constraints in Japan** [high] — Medical service corporations operate under Japanese medical-care rules and clinic licensing requirements. - **Demand sensitivity in aesthetic medicine** [medium] — Cosmetic procedures are discretionary and can be affected by consumer spending and competition. - Customer concentration in a small number of clinic operators - Related-party structure can increase governance and dependency risk - Japan regulatory and medical-services compliance risk - JPY/USD exchange-rate swings affect reported results - Demand for cosmetic procedures can be cyclical ## Accounting Revenue is spread across franchising, procurement, rental, and other service streams, so timing and classification of contracts matter for comparability. The company also has meaningful foreign currency translation exposure because its operations are primarily in Japan but its reporting currency is U.S. dollars, and it uses estimates for consolidation, related-party arrangements, and asset valuations. - **Revenue recognition by service line** — Affects quarterly revenue mix and comparability - **Foreign currency translation** — Can materially change reported revenue, costs, and earnings - **Related-party consolidation and disclosures** — Affects consolidation judgments and disclosure quality - **Estimates for assets and acquired businesses** — Can affect depreciation, amortization, and impairment risk - Revenue recognition across multiple service and procurement streams - Contract classification affects franchising versus procurement revenue - JPY translation into USD affects reported revenue and expenses - Related-party arrangements require careful disclosure and consolidation - Estimates may affect asset values and contingent obligations --- *Last updated: 2026-04-29T04:54:38.098152+00:00*